Is VRCI or ABDX more profitable?

Abingdon Health has a net margin of -33.88% compared to Verici Dx's net margin of -468.31%. Abingdon Health's return on equity of -55.91% beat Verici Dx's return on equity. Company Net Margins Return on Equity Return on Assets Verici Dx -468.31% -178.37% -26.14% Abingdon Health -33.88% -55.91% -17.93%

Which has preferable earnings & valuation, GDR or VRCI?

Verici Dx has higher revenue and earnings than genedrive. genedrive is trading at a lower price-to-earnings ratio than Verici Dx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio genedrive £929K 22.99 -£21.22M -£0.79 N/A Verici Dx £1.91M 2.77 -£6.56M -£2.90 N/A

Is GDR or VRCI more profitable?

Verici Dx has a net margin of -468.31% compared to genedrive's net margin of -500.75%. Verici Dx's return on equity of -178.37% beat genedrive's return on equity. Company Net Margins Return on Equity Return on Assets genedrive -500.75% -1,044.57% -74.09% Verici Dx -468.31% -178.37% -26.14%

Is YGEN or VRCI more profitable?

Yourgene Health has a net margin of -27.55% compared to Verici Dx's net margin of -468.31%. Yourgene Health's return on equity of -27.06% beat Verici Dx's return on equity. Company Net Margins Return on Equity Return on Assets Yourgene Health -27.55% -27.06% -6.71% Verici Dx -468.31% -178.37% -26.14%

Which has preferable valuation & earnings, VRCI or AGL?

Verici Dx has higher earnings, but lower revenue than ANGLE. ANGLE is trading at a lower price-to-earnings ratio than Verici Dx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Verici Dx £1.91M 2.77 -£6.56M -£2.90 N/A ANGLE £2.62M 2.89 -£21.76M -£4.80 N/A

Is VRCI or AGL more profitable?

Verici Dx has a net margin of -468.31% compared to ANGLE's net margin of -732.40%. ANGLE's return on equity of -89.82% beat Verici Dx's return on equity. Company Net Margins Return on Equity Return on Assets Verici Dx -468.31% -178.37% -26.14% ANGLE -732.40% -89.82% -29.89%

Does the media refer more to VRCI or AGL?

In the previous week, Verici Dx had 1 more articles in the media than ANGLE. MarketBeat recorded 2 mentions for Verici Dx and 1 mentions for ANGLE. ANGLE's average media sentiment score of -0.28 beat Verici Dx's score of -1.52 indicating that ANGLE is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Verici Dx 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Very Negative ANGLE 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better earnings and valuation, GENI or VRCI?

GENinCode has higher revenue and earnings than Verici Dx. GENinCode is trading at a lower price-to-earnings ratio than Verici Dx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio GENinCode £2.91M 2.34 -£6.10M -£2.35 N/A Verici Dx £1.91M 2.77 -£6.56M -£2.90 N/A

Is GENI or VRCI more profitable?

GENinCode has a net margin of -185.47% compared to Verici Dx's net margin of -468.31%. Verici Dx's return on equity of -178.37% beat GENinCode's return on equity. Company Net Margins Return on Equity Return on Assets GENinCode -185.47% -409.40% -63.99% Verici Dx -468.31% -178.37% -26.14%

Verici Dx (VRCI) Competitors

GBX 0.35 -0.03 (-6.67%)

As of 12:26 PM Eastern

Compare

VRCI vs. ABDX, GDR, YGEN, AGL, and GENI

Should you buy Verici Dx stock or one of its competitors? MarketBeat compares Verici Dx with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Verici Dx include Abingdon Health (ABDX), genedrive (GDR), Yourgene Health (YGEN), ANGLE (AGL), and GENinCode (GENI). These companies are all part of the "diagnostics & research" industry.

How does Verici Dx compare to Abingdon Health?

Verici Dx (LON:VRCI) and Abingdon Health (LON:ABDX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, media sentiment, dividends, valuation and earnings.

Abingdon Health has higher revenue and earnings than Verici Dx. Abingdon Health is trading at a lower price-to-earnings ratio than Verici Dx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Verici Dx	£1.91M	2.77	-£6.56M	-£2.90	N/A
Abingdon Health	£9.57M	2.66	-£796.37K	-£0.81	N/A

Abingdon Health has a net margin of -33.88% compared to Verici Dx's net margin of -468.31%. Abingdon Health's return on equity of -55.91% beat Verici Dx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Verici Dx	-468.31%	-178.37%	-26.14%
Abingdon Health	-33.88%	-55.91%	-17.93%

Verici Dx has a beta of 1.258, meaning that its stock price is 26% more volatile than the broader market. Comparatively, Abingdon Health has a beta of 0.18, meaning that its stock price is 82% less volatile than the broader market.

In the previous week, Verici Dx had 2 more articles in the media than Abingdon Health. MarketBeat recorded 2 mentions for Verici Dx and 0 mentions for Abingdon Health. Abingdon Health's average media sentiment score of 0.00 beat Verici Dx's score of -1.52 indicating that Abingdon Health is being referred to more favorably in the news media.

Company	Overall Sentiment
Verici Dx	Very Negative
Abingdon Health	Neutral

15.7% of Verici Dx shares are owned by institutional investors. Comparatively, 3.7% of Abingdon Health shares are owned by institutional investors. 1.2% of Verici Dx shares are owned by company insiders. Comparatively, 8.0% of Abingdon Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Abingdon Health beats Verici Dx on 8 of the 13 factors compared between the two stocks.

How does Verici Dx compare to genedrive?

genedrive (LON:GDR) and Verici Dx (LON:VRCI) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, dividends, risk, earnings, analyst recommendations, media sentiment, valuation and profitability.

genedrive has a beta of 1.024, meaning that its share price is 2% more volatile than the broader market. Comparatively, Verici Dx has a beta of 1.258, meaning that its share price is 26% more volatile than the broader market.

In the previous week, Verici Dx had 2 more articles in the media than genedrive. MarketBeat recorded 2 mentions for Verici Dx and 0 mentions for genedrive. genedrive's average media sentiment score of 0.00 beat Verici Dx's score of -1.52 indicating that genedrive is being referred to more favorably in the media.

Company	Overall Sentiment
genedrive	Neutral
Verici Dx	Very Negative

Verici Dx has higher revenue and earnings than genedrive. genedrive is trading at a lower price-to-earnings ratio than Verici Dx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
genedrive	£929K	22.99	-£21.22M	-£0.79	N/A
Verici Dx	£1.91M	2.77	-£6.56M	-£2.90	N/A

Verici Dx has a net margin of -468.31% compared to genedrive's net margin of -500.75%. Verici Dx's return on equity of -178.37% beat genedrive's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
genedrive	-500.75%	-1,044.57%	-74.09%
Verici Dx	-468.31%	-178.37%	-26.14%

0.1% of genedrive shares are owned by institutional investors. Comparatively, 15.7% of Verici Dx shares are owned by institutional investors. 29.0% of genedrive shares are owned by insiders. Comparatively, 1.2% of Verici Dx shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Verici Dx beats genedrive on 9 of the 13 factors compared between the two stocks.

How does Verici Dx compare to Yourgene Health?

Yourgene Health (LON:YGEN) and Verici Dx (LON:VRCI) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk and analyst recommendations.

Yourgene Health has a beta of 0.86, suggesting that its share price is 14% less volatile than the broader market. Comparatively, Verici Dx has a beta of 1.258, suggesting that its share price is 26% more volatile than the broader market.

In the previous week, Verici Dx had 2 more articles in the media than Yourgene Health. MarketBeat recorded 2 mentions for Verici Dx and 0 mentions for Yourgene Health. Yourgene Health's average media sentiment score of 0.00 beat Verici Dx's score of -1.52 indicating that Yourgene Health is being referred to more favorably in the media.

Company	Overall Sentiment
Yourgene Health	Neutral
Verici Dx	Very Negative

23.3% of Yourgene Health shares are owned by institutional investors. Comparatively, 15.7% of Verici Dx shares are owned by institutional investors. 64.4% of Yourgene Health shares are owned by insiders. Comparatively, 1.2% of Verici Dx shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Verici Dx has lower revenue, but higher earnings than Yourgene Health. Verici Dx is trading at a lower price-to-earnings ratio than Yourgene Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Yourgene Health	£29.67M	0.00	-£8.17M	-£0.01	N/A
Verici Dx	£1.91M	2.77	-£6.56M	-£2.90	N/A

Yourgene Health has a net margin of -27.55% compared to Verici Dx's net margin of -468.31%. Yourgene Health's return on equity of -27.06% beat Verici Dx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Yourgene Health	-27.55%	-27.06%	-6.71%
Verici Dx	-468.31%	-178.37%	-26.14%

Summary

Yourgene Health beats Verici Dx on 8 of the 12 factors compared between the two stocks.

How does Verici Dx compare to ANGLE?

Verici Dx (LON:VRCI) and ANGLE (LON:AGL) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, earnings, risk, analyst recommendations, valuation and institutional ownership.

In the previous week, Verici Dx had 1 more articles in the media than ANGLE. MarketBeat recorded 2 mentions for Verici Dx and 1 mentions for ANGLE. ANGLE's average media sentiment score of -0.28 beat Verici Dx's score of -1.52 indicating that ANGLE is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Verici Dx	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Very Negative
ANGLE	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

15.7% of Verici Dx shares are held by institutional investors. Comparatively, 17.5% of ANGLE shares are held by institutional investors. 1.2% of Verici Dx shares are held by company insiders. Comparatively, 2.7% of ANGLE shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Verici Dx has a beta of 1.258, indicating that its stock price is 26% more volatile than the broader market. Comparatively, ANGLE has a beta of 0.22, indicating that its stock price is 78% less volatile than the broader market.

Verici Dx has higher earnings, but lower revenue than ANGLE. ANGLE is trading at a lower price-to-earnings ratio than Verici Dx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Verici Dx	£1.91M	2.77	-£6.56M	-£2.90	N/A
ANGLE	£2.62M	2.89	-£21.76M	-£4.80	N/A

Verici Dx has a net margin of -468.31% compared to ANGLE's net margin of -732.40%. ANGLE's return on equity of -89.82% beat Verici Dx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Verici Dx	-468.31%	-178.37%	-26.14%
ANGLE	-732.40%	-89.82%	-29.89%

Summary

Verici Dx beats ANGLE on 7 of the 13 factors compared between the two stocks.

How does Verici Dx compare to GENinCode?

GENinCode (LON:GENI) and Verici Dx (LON:VRCI) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, media sentiment, profitability, valuation, earnings and institutional ownership.

GENinCode has higher revenue and earnings than Verici Dx. GENinCode is trading at a lower price-to-earnings ratio than Verici Dx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GENinCode	£2.91M	2.34	-£6.10M	-£2.35	N/A
Verici Dx	£1.91M	2.77	-£6.56M	-£2.90	N/A

In the previous week, Verici Dx had 2 more articles in the media than GENinCode. MarketBeat recorded 2 mentions for Verici Dx and 0 mentions for GENinCode. GENinCode's average media sentiment score of 0.00 beat Verici Dx's score of -1.52 indicating that GENinCode is being referred to more favorably in the media.

Company	Overall Sentiment
GENinCode	Neutral
Verici Dx	Very Negative

GENinCode has a net margin of -185.47% compared to Verici Dx's net margin of -468.31%. Verici Dx's return on equity of -178.37% beat GENinCode's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GENinCode	-185.47%	-409.40%	-63.99%
Verici Dx	-468.31%	-178.37%	-26.14%

4.5% of GENinCode shares are owned by institutional investors. Comparatively, 15.7% of Verici Dx shares are owned by institutional investors. 8.7% of GENinCode shares are owned by insiders. Comparatively, 1.2% of Verici Dx shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

GENinCode has a beta of 0.588, meaning that its stock price is 41% less volatile than the broader market. Comparatively, Verici Dx has a beta of 1.258, meaning that its stock price is 26% more volatile than the broader market.

Summary

Verici Dx beats GENinCode on 7 of the 13 factors compared between the two stocks.

Get Verici Dx News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VRCI vs. The Competition

Export

Metric	Verici Dx	Diagnostics & Research Industry	Medical Sector	LON Exchange
Market Cap	£5.30M	£612.95M	£6.81B	£2.77B
Dividend Yield	N/A	3.36%	2.68%	6.16%
P/E Ratio	-0.12	78.86	25.79	366.66
Price / Sales	2.77	629.06	548.63	85,978.63
Price / Cash	1.31	11.42	46.33	27.87
Price / Book	0.08	3.24	10.77	7.76
Net Income	-£6.56M	£334.07B	£3.57B	£5.89B
7 Day Performance	-7.41%	1.23%	3.15%	-0.71%
1 Month Performance	-12.50%	-3.34%	2.34%	-1.20%
1 Year Performance	-71.54%	2.38%	33.41%	65.93%

Verici Dx Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
VRCI Verici Dx	N/A	GBX 0.35 -6.7%	N/A	-72.0%	£5.30M	£1.91M	N/A	19	News Coverage Negative News Gap Up
ABDX Abingdon Health	N/A	GBX 12.06 -4.3%	N/A	+69.0%	£31.64M	£9.57M	N/A	84	Gap Down
GDR genedrive	N/A	GBX 1.24 +5.5%	N/A	-6.4%	£18.87M	£929K	N/A	43	Positive News Gap Up
YGEN Yourgene Health	N/A	N/A	N/A	N/A	£16.43M	£29.67M	N/A	253
AGL ANGLE	N/A	GBX 2.35 -11.3%	N/A	-68.7%	£7.58M	£2.62M	N/A	650	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:VRCI) was last updated on 6/26/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Verici Dx (VRCI) Competitors

VRCI vs. ABDX, GDR, YGEN, AGL, and GENI

How does Verici Dx compare to Abingdon Health?

Summary

How does Verici Dx compare to genedrive?

Summary

How does Verici Dx compare to Yourgene Health?

Summary

How does Verici Dx compare to ANGLE?

Summary

How does Verici Dx compare to GENinCode?

Summary

VRCI vs. The Competition

Verici Dx Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Verici Dx (VRCI) Competitors

VRCI vs. ABDX, GDR, YGEN, AGL, and GENI

How does Verici Dx compare to Abingdon Health?

Which has stronger valuation and earnings, VRCI or ABDX?

Is VRCI or ABDX more profitable?

Which has more volatility and risk, VRCI or ABDX?

Does the media prefer VRCI or ABDX?

Do institutionals & insiders believe in VRCI or ABDX?

Summary

How does Verici Dx compare to genedrive?

Which has more risk and volatility, GDR or VRCI?

Does the media refer more to GDR or VRCI?

Which has preferable earnings & valuation, GDR or VRCI?

Is GDR or VRCI more profitable?

Do institutionals and insiders have more ownership in GDR or VRCI?

Summary

How does Verici Dx compare to Yourgene Health?

Which has more volatility & risk, YGEN or VRCI?

Does the media prefer YGEN or VRCI?

Do institutionals and insiders hold more shares of YGEN or VRCI?

Which has better earnings & valuation, YGEN or VRCI?

Is YGEN or VRCI more profitable?

Summary

How does Verici Dx compare to ANGLE?

Does the media refer more to VRCI or AGL?

Do insiders & institutionals believe in VRCI or AGL?

Which has more volatility and risk, VRCI or AGL?

Which has preferable valuation & earnings, VRCI or AGL?

Is VRCI or AGL more profitable?

Summary

How does Verici Dx compare to GENinCode?

Which has better earnings and valuation, GENI or VRCI?

Does the media favor GENI or VRCI?

Is GENI or VRCI more profitable?

Do institutionals and insiders believe in GENI or VRCI?

Which has more risk & volatility, GENI or VRCI?

Summary

VRCI vs. The Competition

Verici Dx Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools